Arcosa
ACA

Arcosa (ACA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
OppenheimerInitiated CoverageOutperform$150.00May 28, 2026
BarclaysMaintainedOverweight$140.00 from $115.00May 4, 2026
DA DavidsonMaintainedBuy$125.00 from $120.00Mar 2, 2026
BarclaysMaintainedOverweight$115.00 from $106.00Nov 3, 2025
DA DavidsonMaintainedBuy$120.00 from $110.00Aug 11, 2025
OppenheimerMaintainedOutperform$110.00 from $105.00Jan 14, 2025
BarclaysInitiated CoverageOverweight$106.00Oct 29, 2024
OppenheimerMaintainedOutperform$105.00 from $100.00Aug 19, 2024
Stephens & Co.UpgradedEqual-Weight → Overweight$96.00Aug 7, 2024
DA DavidsonMaintainedBuy$110.00 from $105.00May 17, 2024
DA DavidsonMaintainedBuy$95.00 from $90.00Feb 28, 2024
OppenheimerMaintainedOutperform$90.00 from $85.00Feb 23, 2024
Sidoti & Co.UpgradedNeutral → Buy$90.00Oct 17, 2023
Stephens & Co.MaintainedEqual-Weight$87.00 from $77.00Aug 8, 2023
Loop CapitalMaintainedBuy$88.00 from $80.00Aug 7, 2023
DA DavidsonMaintainedBuy$90.00 from $85.00Aug 7, 2023
OppenheimerMaintainedOutperform$85.00 from $75.00May 8, 2023
DA DavidsonMaintainedBuy$85.00 from $80.00May 1, 2023
Loop CapitalMaintainedBuy$80.00 from $75.00May 1, 2023

Frequently asked questions

  • What is the latest analyst rating on ACA?

    On May 28, 2026, Oppenheimer initiated coverage of Arcosa at Outperform with a price target of $150.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.